Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drugs in Development for Hepatitis B
Altaf Dawood, Syed Abdul Basit, Mahendran Jayaraj, et al.
Drugs (2017) Vol. 77, Iss. 12, pp. 1263-1280
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Current epidemiology in hepatocellular carcinoma
Peter Konyn, Aijaz Ahmed, Donghee Kim
Expert Review of Gastroenterology & Hepatology (2021) Vol. 15, Iss. 11, pp. 1295-1307
Closed Access | Times Cited: 195
Interaction between Hepatitis B Virus and Toll-Like Receptors: Current Status and Potential Therapeutic Use for Chronic Hepatitis B
Zhiyong Ma, Qian Cao, Yong Xiong, et al.
Vaccines (2018) Vol. 6, Iss. 1, pp. 6-6
Open Access | Times Cited: 76
Antiviral activity of a polysaccharide from Radix Isatidis (Isatis indigotica Fortune) against hepatitis B virus (HBV) in vitro via activation of JAK/STAT signal pathway
Tianbao Wang, Xinwei Wang, Ya Zhuo, et al.
Journal of Ethnopharmacology (2020) Vol. 257, pp. 112782-112782
Closed Access | Times Cited: 58
Recent advances in the development of HBV capsid assembly modulators
Bhavitavya Nijampatnam, Dennis C. Liotta
Current Opinion in Chemical Biology (2019) Vol. 50, pp. 73-79
Closed Access | Times Cited: 55
Preclinical Profile and Characterization of the Hepatitis B Virus Core Protein Inhibitor ABI-H0731
Qi Huang, Dawei Cai, Ran Yan, et al.
Antimicrobial Agents and Chemotherapy (2020) Vol. 64, Iss. 11
Open Access | Times Cited: 47
Present and Future Therapies for Chronic Hepatitis B
Ya-Chao Tao, Dongbo Wu, Lingyun Zhou, et al.
Advances in experimental medicine and biology (2019), pp. 137-186
Closed Access | Times Cited: 37
Heat shock protein 70 and heat shock protein 90 synergistically increase hepatitis B viral capsid assembly
Hyun Wook Seo, Joon Pyung Seo, Guhung Jung
Biochemical and Biophysical Research Communications (2018) Vol. 503, Iss. 4, pp. 2892-2898
Closed Access | Times Cited: 32
Cetylpyridinium chloride interaction with the hepatitis B virus core protein inhibits capsid assembly
Hyun Wook Seo, Joon Pyung Seo, Yuri Cho, et al.
Virus Research (2019) Vol. 263, pp. 102-111
Closed Access | Times Cited: 25
The Dihydroquinolizinone Compound RG7834 Inhibits the Polyadenylase Function of PAPD5 and PAPD7 and Accelerates the Degradation of Matured Hepatitis B Virus Surface Protein mRNA
Liren Sun, Fang Zhang, Fang Guo, et al.
Antimicrobial Agents and Chemotherapy (2020) Vol. 65, Iss. 1
Open Access | Times Cited: 21
Critical Updates on Chronic Hepatitis B Virus Infection in 2021
Cyriac Abby Philips, Rizwan Ahamed, Jinsha K Abduljaleel, et al.
Cureus (2021)
Open Access | Times Cited: 20
Viral Factors in Modulation of Host Immune Response: A Route to Novel Antiviral Agents and New Therapeutic Approaches
Olga Tarasova, Anthi Petrou, Sergey M. Ivanov, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9408-9408
Open Access | Times Cited: 2
Potential capacity of interferon-α to eliminate covalently closed circular DNA (cccDNA) in hepatocytes infected with hepatitis B virus
Gang Wang, Jun Guan, Nazif Ullah Khan, et al.
Gut Pathogens (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 16
Challenges, Considerations, and Principles to Guide Trials of Combination Therapies for Chronic Hepatitis B Virus
Ryan T. Anderson, Seng Gee Lim, Poonam Mishra, et al.
Gastroenterology (2018) Vol. 156, Iss. 3, pp. 529-533.e4
Open Access | Times Cited: 18
Interleukin-7 augments CD8+ T cells function and promotes viral clearance in chronic hepatitis C virus infection
H R Hou, Yi Kang, Yanli Zeng, et al.
Cytokine (2017) Vol. 102, pp. 26-33
Closed Access | Times Cited: 17
Sulfamoylbenzamide-based Capsid Assembly Modulators for Selective Inhibition of Hepatitis B Viral Replication
Yeon Hee Lee, Hyeon‐Min Cha, Jun Yeon Hwang, et al.
ACS Medicinal Chemistry Letters (2021) Vol. 12, Iss. 2, pp. 242-248
Open Access | Times Cited: 13
Drug Delivery Strategies for Antivirals against Hepatitis B Virus
Latavia Singh, Sunaina Indermun, Mershen Govender, et al.
Viruses (2018) Vol. 10, Iss. 5, pp. 267-267
Open Access | Times Cited: 16
Emerging Therapies Toward a Functional Cure for Hepatitis B Virus Infection.
W. Ray Kim
PubMed (2018) Vol. 14, Iss. 7, pp. 439-442
Closed Access | Times Cited: 16
A dendritic cell receptor-targeted chimeric immunotherapeutic protein (C-HBV) for the treatment of chronic hepatitis B
Allan Ma, Bruce Motyka, Klaus S. Gutfreund, et al.
Human Vaccines & Immunotherapeutics (2019) Vol. 16, Iss. 4, pp. 756-778
Open Access | Times Cited: 12
The SAR-based development of small molecular HBV capsid assembly modulators
Yunwen Wang, Shendan Wang, Xuefen Tao, et al.
Medicinal Chemistry Research (2022) Vol. 31, Iss. 9, pp. 1414-1430
Closed Access | Times Cited: 6
Sesquiterpenoids from aged Artemisia argyi and their 3D-QSAR for anti-HBV activity
Yu-Ying Song, Yongzhi Zhou, Yun-Fen Wang, et al.
Phytochemistry (2023) Vol. 217, pp. 113912-113912
Closed Access | Times Cited: 3
Effect of recombinant human interleukin-7 on Pseudomonas aeruginosa wound infection
S. M. Grigorieva, D. B. Starosyla, С. Л. Рыбалко, et al.
The Ukrainian Biochemical Journal (2019) Vol. 91, Iss. 5, pp. 7-15
Open Access | Times Cited: 8
Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II Trial
Chien‐Ting Lin, Po‐Ren Hsueh, Shang‐Ju Wu, et al.
Biology of Blood and Marrow Transplantation (2018) Vol. 24, Iss. 11, pp. 2310-2315
Open Access | Times Cited: 6
Acetophenone 4-nitrophenylhydrazone inhibits Hepatitis B virus replication by modulating capsid assembly
M. Yamasaki, Norie Matsuda, Kazuaki Matoba, et al.
Virus Research (2021) Vol. 306, pp. 198565-198565
Open Access | Times Cited: 6
Development of antiviral drugs against hepatitis B virus
Yingan Jiang, Yuchen Xia, Kaitao Zhao, et al.
Chinese Science Bulletin (Chinese Version) (2019) Vol. 64, Iss. 30, pp. 3123-3141
Open Access | Times Cited: 5
Molecular mechanisms of tetrahydropyrrolo[1,2-c]pyrimidines as HBV capsid assembly inhibitors
Li Ting Song, Rui Rui Liu, Hong Lin Zhai, et al.
Archives of Biochemistry and Biophysics (2018) Vol. 663, pp. 1-10
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top